The Uses of Low-Dose Naltrexone in Clinical Practice (Abstract)

The LDN Conference 2021: 4th - 6th June 2021

Up to 29 CME Credits Available + Sponsor, Exhibitor and Advertiser Opportunities.  [More Details]

The Uses of Low-Dose Naltrexone in Clinical Practice

BMJ Case Reports
January 2018

The purpose of this paper is to review low-dose naltrexone (LDN) for use in clinical practice. The known or theoretical mechanism of action of LDN, clinical research findings in relation to various medical conditions including pain, autoimmune conditions, cancer, and mood disorders will be discussed. Recommended doses and forms of LDN will also be summarized.

Keywords: low-dose naltrexone, LDN, clinical research, ENDO1639A, OGF/OGFr axis, autoimmune conditions, rheumatoid arthritis, Crohn’s disease, multiple sclerosis, post traumatic stress syndrome

Keywords by  Erin Williams, student, St. Louis College of Pharmacy